Akura Medical

About Akura Medical

Akura Medical is dedicated to revolutionizing thrombectomy care by addressing the limitations of existing treatment options for venous thromboembolism (VTE). Their mission is to treat more patients faster, more accurately, and more efficiently through enhanced intraoperative feedback.

Products & Services

Katana™ Thrombectomy System:Engineered to access and remove clots of different morphologies quickly and efficiently. Features include the Katana catheter for navigating complex anatomy, HydroBlade™ jets for swift clot removal without clogging, and the Sentinel™ console for clot engagement insights and reduced procedural uncertainty. Not cleared for sale in the USA or approved in any country.

Specialties

Thrombectomy Care Venous Thromboembolism (VTE) Treatment Medical Device Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 53000000 MR: - FA: $53 million FAN: 53000000	D: 2025-12-01 FD: 2025-12-01	1 investors

Series C Latest

2025-12-01

$53.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Amr Salahieh

Chair & Acting CEO

A

Aadel Al-Jadda

Co-Founder & VP of R&D

T

Theresa Brandner

Vice President, Regulatory Affairs

P

Praveen Dala

Vice President, Console

J

Joann Heberer

Senior Vice President, QA

F

Faisal Khan

Senior Director, Marketing

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Akura Medical Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised